RxDoctor Payments Data

Aaron Peimann

Family Medicine · Fort Dodge, IANPI 1336111657

Payments from drug & device makers

$1,995in general payments, 2019–2025

Across 155 payments — averaging $12.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$309
  • GSK$240
  • AstraZeneca$176
  • Amgen$168
  • Boehringer Ingelheim$141
  • AbbVie$136
  • plus $825 from 14 others

What the payments were for

  • Food & beverage$1,97699%
  • Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,995 in reported general payments places this provider in the 85th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin131$131,621
EliquisApixaban126$91,464
OzempicSemaglutide50$48,189
XareltoRivaroxaban36$34,700
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr56$25,409
TrulicityDulaglutide20$21,069
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$19,348
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$14,079
JanuviaSitagliptin Phosphate13$14,030
Tresiba Flextouch U-100Insulin Degludec25$13,151
EntrestoSacubitril/Valsartan12$10,639
MyrbetriqMirabegron19$9,471
LumiganBimatoprost21$5,122
Atorvastatin Calcium542$3,882
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,734

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$141$145,700143 claims
PfizerEliquis$309$91,464126 claims
Novo NordiskOzempic$80$48,18950 claims
GSKAnoro Ellipta, Trelegy Ellipta$240$44,75776 claims
Johnson & JohnsonXarelto$47$34,70036 claims
Lilly USA, LLCTrulicity$118$21,06920 claims
MerckJanuvia$39$14,03013 claims
NovartisEntresto$82$10,63912 claims
Astellas Pharma US IncMyrbetriq$123$9,47119 claims
AbbVieLumigan$136$5,12221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Fort Dodge

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →